Amphastar (AMPH) to Report Q4 Earnings: What's in the Cards? [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
Amphastar's pharmaceutical products, such as Glucagon, Primatene Mist, Epinephrine and Lidocaine, are the major contributors to its top line, which accounted for about 50% of the company's total net revenues in the third quarter of 2023. Let us see how things have shaped up for the quarter to be reported. Factors to Consider Amphastar reports its revenues under two segments — Product revenues and Other revenues. The company's Product revenues segment comprises sales of its Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). Under the Other revenues segment, AMPH records net revenues from the sales of Baqsimi, which AMPH acquired from Eli Lilly in June 2023. Baqsimi is a dry nasal spray to treat very low blood sugar in people with diabetes aged four years and above. The addition of this product to AMPH's portfolio provides the company with a branded product with growing sales and a strong gross margin, thus strengthening its intranasal product portf
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024Accesswire
- Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth [Yahoo! Finance]Yahoo! Finance
- Pharvaris appoints David Nassif as chief financial officer [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 2/28/24 - Beat
AMPH
Sec Filings
- 5/1/24 - Form 144
- 4/19/24 - Form DEFA14A
- 4/12/24 - Form ARS
- AMPH's page on the SEC website